The U.S. Department of the Army Medical Command awarded a $3,908,980.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Case Western Reserve University (CWRU) to enhance walking and independence for individuals with incomplete spinal cord injuries through the development of a fully implanted neuroprosthesis. The award, effective September 15, 2024 through September 14, 2028, will support advanced biomedical research and technology innovation to...
This federal Project Grant award for $773,399.00, funded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports research at Case Western Reserve University to investigate neuromodulation for improving bladder function in a large animal model of spinal cord injury (SCI). The award, which runs from September 30, 2024 to September 29, 2027, will enable the university's researchers to explore innovative approaches to...
The Department of the Army Medical Command awarded Case Western Reserve University a $1,288,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to therapeutically target superclusters at genes driving childhood sarcoma from September 2021 through September 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through...
The Department of the Army Medical Command awarded Case Western Reserve University a $795,901 project grant under the Military Medical Research and Development program (CFDA 12.420). The university will develop a novel agent targeting microglial activation induced by therapeutic brain irradiation over a three year period ending August 31, 2025. Through this funding, the awardee aims to investigate medical solutions for the battlefield and transform health care for service members and the...
This Project Grant award, valued at $3,999,779.00 and awarded on June 1, 2024, is funded by the U.S. Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The objective of this award is to develop a personalized, patient-centered prosthetic foot prescription and rehabilitation strategy to maximize mobility and satisfaction in veterans with lower limb loss. The prime awardee is Northwestern University, and the project...
Case Western Reserve University will receive $2,469,361 from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program to support the SANGUISTOP project. This four-year Project Grant will fund research into intravenous nanomedicine for targeted thrombin delivery in hemorrhage control. The Military Medical Research and Development program aims to transform military and public health care through innovative medical solutions for...
The U.S. Department of Defense (DoD) Defense Health Agency awarded a $1,820,004 Project Grant to Case Western Reserve University's Office of Research Administration Division, doing business as the University Hospitals of Cleveland, under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "HEMOSEAL: COMBINATORIAL NANOPARTICLE TECHNOLOGY FOR POINT-OF-INJURY HEMORRHAGE CONTROL," will support the development of an innovative nanoparticle-based technology...
The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
The U.S. Department of Defense (DoD) awarded a $497,747 project grant to Case Western Reserve University's Office of Research Administration Division (doing business as University Hospitals of Cleveland) under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a novel, central nervous system-penetrant synthetic oleanane triterpenoid for the treatment of diffuse intrinsic pontine glioma (DIPG), a rare and aggressive form of pediatric brain...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded The Cleveland Clinic Foundation a $1,448,174 Project Grant on June 1, 2024 to fund research on "INTUITIVE ULTRASOUND-BASED UPPER LIMB PROSTHETIC CONTROL AND FEEDBACK UTILIZING TARGETED REINNERVATION FOR NEUROMA PAIN." The research, conducted in collaboration with the University of California, Davis as a sub-awardee, aims to establish sonomyographic control parameters for patients with...